期刊文献+

腹膜后局灶性Castleman病2例报告并文献复习 被引量:1

原文传递
导出
摘要 目的:复习Castleman病的原因,提高Castleman病的诊治水平。方法:回顾性分析收治2例腹膜后局灶性Castleman病患者的临床病例资料,结合复习相关文献。结果:2例腹膜后局灶性Castleman病患者均无明显临床症状及体征,为B超检查偶然发现;呈单个淋巴结增生,表现为腹膜后占位性病变;均行肿物切除术,病理确诊为Castleman病,术后随访无复发。结论:腹膜后局灶性Castleman病主要表现为单一部位的淋巴结肿大,多无临床症状,也无实验室异常检测结果及特征性影像学表现。术前不易明确诊断,最终的确诊依靠病理诊断。该病手术切除疗效好,术后可长期生存。
出处 《临床泌尿外科杂志》 2013年第5期395-398,共4页 Journal of Clinical Urology
  • 相关文献

参考文献13

  • 1Marshall V, Parks T,Bagni R,et al. Conservation ofvirally encoded microRNAs in Kaposi sarcoma- associat-ed herpesvirus in primary effusion lymphoma cell linesand in patients witlb Kaposi sarcoma or multicentricCastleman disease[J]. J Infect Dis,2007,195 : 645 —659.
  • 2Tedeschi R,Marus A,Bidoli E,et al. Human herpes-virus 8 DNA quantification in matched plasma and PB-MCs samples of patients with HHV8-related lympho-proliferative diseases[J]. J Clin Virol,2008,43: 255-259.
  • 3Tomonari A,Shirafuji N,Tojo A,et al. Acute my-elogenous leukemia M5b developed during clinical re-mission of Castleman disease[J]. Int J Hematol, 2003,77: 274 — 276.
  • 4Dham A, Peterson B A. Castleman disease [J]. CurrOpin Hematol, 2007,14 ; 354 — 359.
  • 5Nishimoto N,Kishimoto T. Interleukin 6 : from benchto bedside [J]. Nat Clin Pract Rheumatol, 2006,2 :619-626.
  • 6Dispenzieri A. Castleman disease [J]. Cancer TreatRes,2008,142: 293 — 330.
  • 7Choi J H,Jo Y J,Gong S J. et al. Unicentric castle-man disease is not clearly distinguished from multicen-tric type: a case report[J]. Clin Lymphoma Myeloma ,2008,8: 256-259.
  • 8Naresh K N, Rice A J,Bower M. Lymph nodes in-volved by multicentric Castleman disease among HIV-positive individuals are often involved by Kaposi sarco-ma[J], Am J Surg Pathol, 2008, 32: 1006 — 1012.
  • 9Kim T J, Han J K,Kim Y H, et al. Castleman diseaseof the abdomen: imaging spectrum and clinicopatholog-ic correlations [J]. J Comput Assist Tomogr, 2001,25: 207-214.
  • 10Nishimoto N,Kanakura Y,Aozasa K, et al. Human-ized anti-interleukin-6 receptor antibody treatment ofmulticentric Castleman disease[J]. Blood,2005,106 :2627-2632.

同被引文献15

  • 1Newlon JL,Couch M,Brennan J.Castleman's disease:three Case reports and a review of the literature[J]Ear Nose Throat J,2007,86(7):414-418.
  • 2Kawabta H,Tomosugi N,Kanda J,et al.Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castlemans[J].Haematologica,2007,92(6):857-858.
  • 3Powles T,Stebbing J,Montoto S,et al.Rituximab as reTreatment for rituximab pretreated HIV-associated multicen-Tric Castleman disease[J].Blood,2007,110(12):4132-4133.
  • 4Bowne WB,Lewis JJ,Filippa DA,et al.The management Of unicentric and multicentrec Castleman's disease:areport of 16 cases and a review of the literature[J].Cancer,1999,85(3):706-717.
  • 5Bestawros A,Michel R,Séguin C,et al.Multicentric CastleMans disease treated with combination chemotherapy and rit-Uximab in four HIV-positive men:a case series[J].Am J Hematol,2008,83(6):508-511.
  • 6Neuhof D,Debus J.Outcome and late complications of radiotherapy in patients with unicentric Castleman disease[J].Acta Oncol,2006,45(8):1126-1131.
  • 7Ocio EM,Sanchez-Guijo FM,Diez-cpelo M.Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena[J].Am J Hematol,2005,78(4):302-305.
  • 8Dispenzieri A.Castleman disease[J].Cancer Treat Res,2008,142:293-330.
  • 9余国攀,王书杰,师杰,赵永强.Castleman病的临床特点和预后[J].中国医学科学院学报,2009,31(5):570-574. 被引量:26
  • 10刘炜炜,葛春林,陈旭春,李建华,任玲,李璇,王坤.12例多中心型Castleman病的诊断与治疗[J].中国肿瘤临床,2010,37(20):1179-1183. 被引量:12

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部